Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Compare Balance Sheet Results of Vista Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.31
76.85
-64.54
-83.98%
Share Warrants & Outstandings
Total Reserve
33.10
7.31
25.79
352.80%
Shareholder's Funds
45.42
84.16
-38.74
-46.03%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.38
0.18
2.20
1,222.22%
Secured Loans
2.38
0.00
2.38
0.00%
Unsecured Loans
0.00
0.18
-0.18
-100.00%
Deferred Tax Assets / Liabilities
-4.37
0.00
-4.37
0.00%
Other Long Term Liabilities
0.00
2.46
-2.46
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.12
0.00
0.12
0.00%
Total Non-Current Liabilities
-1.87
2.63
-4.50
-171.10%
Current Liabilities
Trade Payables
5.59
3.82
1.77
46.34%
Other Current Liabilities
1.74
0.61
1.13
185.25%
Short Term Borrowings
5.02
0.00
5.02
0.00%
Short Term Provisions
0.01
0.06
-0.05
-83.33%
Total Current Liabilities
12.37
4.49
7.88
175.50%
Total Liabilities
55.92
91.28
-35.36
-38.74%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.18
0.21
26.97
12,842.86%
Less: Accumulated Depreciation
8.48
0.16
8.32
5,200.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18.70
0.05
18.65
37,300.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
10.14
0.00
10.14
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
3.31
-3.26
-98.49%
Long Term Loans & Advances
2.12
10.59
-8.47
-79.98%
Other Non Current Assets
0.00
1.99
-1.99
-100.00%
Total Non-Current Assets
31.01
15.93
15.08
94.66%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.22
9.87
-1.65
-16.72%
Sundry Debtors
13.54
26.69
-13.15
-49.27%
Cash and Bank
0.73
0.40
0.33
82.50%
Other Current Assets
0.41
28.00
-27.59
-98.54%
Short Term Loans and Advances
2.00
10.40
-8.40
-80.77%
Total Current Assets
24.91
75.35
-50.44
-66.94%
Net Current Assets (Including Current Investments)
12.54
70.86
-58.32
-82.30%
Total Current Assets Excluding Current Investments
24.91
75.35
-50.44
-66.94%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
55.92
91.28
-35.36
-38.74%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.40
0.18
7.22
4,011.11%
Book Value per share (adjusted)
7.38
1.12
6.26
558.93%
Annual - Borrowings
Borrowings 7.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 28.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 24.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
